Page last updated: 2024-09-05

darunavir and Behavior Disorders

darunavir has been researched along with Behavior Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonnal, C; Descamps, D; Desselas, E; Giraud, J; Lariven, S; Le Meur, L; Lê, MP; Lillo-Le-Louet, A; Massias, L; Peytavin, G; Sonneville, R; Tantet, C; Yazdanpanah, Y	1
Portilla, J	1
Hill, A; Moecklinghoff, C; Winston, A	1

Reviews

1 review(s) available for darunavir and Behavior Disorders

Article	Year
[Safety and tolerability of etravirine]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27 Suppl 2 Topics: Animals; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Darunavir; Drug Eruptions; Drug Evaluation, Preclinical; Dyslipidemias; Female; Fetus; Gastrointestinal Diseases; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Mental Disorders; Multicenter Studies as Topic; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Sulfonamides	2009

Article

Year

[Safety and tolerability of etravirine].

Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27 Suppl 2

Topics: Animals; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Darunavir; Drug Eruptions; Drug Evaluation, Preclinical; Dyslipidemias; Female; Fetus; Gastrointestinal Diseases; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Mental Disorders; Multicenter Studies as Topic; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Sulfonamides

2009

Other Studies

2 other study(ies) available for darunavir and Behavior Disorders

Article	Year
Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis. The Journal of antimicrobial chemotherapy, 2018, 04-01, Volume: 73, Issue:4 Topics: Anti-HIV Agents; Antifungal Agents; Darunavir; Drug Interactions; Histoplasmosis; HIV Infections; Humans; Itraconazole; Male; Mental Disorders; Middle Aged; Plasma; Ritonavir	2018
Three-year evaluation of neuropsychiatric adverse events in the MONET trial of darunavir/ritonavir, with or without nucleoside analogues. International journal of STD & AIDS, 2012, Volume: 23, Issue:3 Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Female; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Ritonavir; Sulfonamides	2012

Article

Year

Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis.

The Journal of antimicrobial chemotherapy, 2018, 04-01, Volume: 73, Issue:4

Topics: Anti-HIV Agents; Antifungal Agents; Darunavir; Drug Interactions; Histoplasmosis; HIV Infections; Humans; Itraconazole; Male; Mental Disorders; Middle Aged; Plasma; Ritonavir

2018

Three-year evaluation of neuropsychiatric adverse events in the MONET trial of darunavir/ritonavir, with or without nucleoside analogues.

International journal of STD & AIDS, 2012, Volume: 23, Issue:3

Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Female; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Ritonavir; Sulfonamides

2012